Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2024 Q1 | Apr 27, 2024 | White Brook Capital | 0.0% | 6.5% | AFYA, BLDR, GBX, GPRE, KAR, KNX, LTH, PETQ, PTLO, RILY | consumer, healthcare, Pet Care, small caps, Trade Down, value | The manager sees pet care as benefiting from aging pet populations requiring more medications and supplements, while less affluent consumers trade down to cost-effective products like PetIQ's offerings. The company benefits from pets' continued existence rather than just initial purchases, with supplements becoming their largest business segment. | PETQ |
View |
| 2024 Q3 | Oct 22, 2024 | White Brook Capital | 0.0% | 6.5% | AFYA, BLDR, DNUT, GPRE, LTH, MOS, OKTA, PETQ, W | consumer, Housing, M&A, Midcap, technology, value | White Brook maintains a housing recovery thesis backed by a healthy US consumer, investing in Wayfair and Builders First Source. The fund expects lower mortgage rates and housing supply deficits to drive performance over the next 3 years, with hurricane rebuilding providing near-term support. | BLDR GPRE AFYA DNUT OKTA W |
View |
| 2024 Q2 | Jun 30, 2024 | White Brook Capital | - | - | AFYA, BLDR, GPRE | AI, Biofuels, Brazil, Homebuilders, Rate Cuts, small caps, undervalued, value | Manager expresses skepticism about current AI valuations and technology approach, particularly questioning large language models and AI hallucination as features rather than bugs. Notes that mega-cap AI companies are worth more than entire countries' public markets. | AFYA GPRE BLDR |
View |
| 2024 Q4 | Jan 27, 2025 | White Brook Capital | - | - | AFYA, BLDR, BOX, DNUT, GBX, GPRE, INFU, KAR, LTH, MOS, OKTA, PTLO, RPID, W | Brazil, Fertilizers, Food, healthcare, Housing, mid cap, technology, value | Two portfolio companies have significant Brazilian operations affected by currency devaluation of over 25% in 2024. Brazilian government passed fiscal measures reducing spending in late 2024, and currency pressures have abated. The manager expects significant returns if Brazil's currency stabilizes or improves versus the dollar. | View | |
| 2023 Q4 | Jan 25, 2024 | White Brook Capital | 0.0% | 6.5% | AFYA, BLDR, GBX, GPRE, MOS, RILY | AI, Biofuels, commodities, Fertilizers, Homebuilders, mid cap, private credit, value | Manager expresses skepticism about AI valuations and implementation challenges. Discusses unresolved issues around data utility, monetization models, and the gap between investment levels and practical effectiveness. Notes that current AI applications like Microsoft Copilot are expensive to develop and poor value for money. | RILY GPRE IMOS BLDR |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | Fund Letters | White Brook Capital | Green Plains Inc | Energy | Oil & Gas Refining & Marketing | Bull | NASDAQ | Activist Target, Biofuels, Corn Processing, Ethanol, renewable energy, Sustainable aviation fuel, turnaround, Value | View Pitch |
| Apr 13, 2026 | Fund Letters | White Brook Capital | Green Plains | Energy | Oil, Gas & Consumable Fuels | Bull | NASDAQ | activist investor, Biofuels, Corn Processing, energy, Ethanol, strategic review, turnaround | View Pitch |
| Apr 13, 2026 | Fund Letters | White Brook Capital | Green Plains Inc | Energy | Oil & Gas Refining & Marketing | Bull | NASDAQ | Activist Situation, Biorefining, Comparable Transactions, Debt Covenant, Ethanol, Management Pressure, Proxy Contest, Sale Catalyst | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| Paul Tudor Jones | Tudor Investment Corp | $53.4B | $4.1M | 0.01% | 417,256 | -345,252 | -45.28% | 0.4402% |
| Steven A. Cohen | Point72 Asset Management | $86.8B | $4.8M | 0.01% | 491,720 | +491,720 | +100.00% | 0.5188% |
| Dmitry Balyasny | Balyasny Asset Management | $76.6B | $1.9M | 0.00% | 197,384 | +152,629 | +341.03% | 0.2083% |
| Israel Englander | Millennium Management LLC | $233.2B | $15.7M | 0.01% | 1,604,915 | +577,489 | +56.21% | 1.6933% |
| Jeremy Grantham | GMO LLC | $39.1B | $39.5M | 0.10% | 4,030,658 | -295,533 | -6.83% | 4.2526% |
| Terrence Murphy | Clearbridge Investments | $124.9B | $6.3M | 0.01% | 640,791 | -59,409 | -8.48% | 0.6761% |
| David Siegel & John Overdeck | Two Sigma Investments | $67.5B | $13.9M | 0.02% | 1,416,418 | +619,041 | +77.63% | 1.4944% |
| Cliff Asness | AQR Capital Management | $190.6B | $3.1M | 0.00% | 316,225 | +132,779 | +72.38% | 0.3336% |
| Cory Martin | Barrow, Hanley, Mewhinney & Strauss | $30.0B | $9,104 | 0.00% | 929 | -104 | -10.07% | 0.0010% |